New state laws aimed at restricting the use, sale, or other disclosure of personally identifiable health data, particularly reproductive health data, reflect growing concerns that existing federal privacy regulations fail to adequately protect those data from third-party access and criminal investigation, Reuters reported.
Featured News
FTC Warns Patent-Right Acquisitions Cannot Escape Antitrust Review in Amgen Enbrel Case
Aug 24, 2026 by
CPI
nVent Bets $1.75 Billion on Data-Center Power Demand
Aug 24, 2026 by
CPI
Squire Patton Boggs Adds Former FTC Antitrust Lawyer
Aug 24, 2026 by
CPI
Tacoma Sues Fire-Truck Makers in Expanding US Antitrust Fight
Aug 24, 2026 by
CPI
California Breaks Off Paramount Talks Over $110 Billion Warner Bros. Deal
Aug 24, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Antipasto
Aug 24, 2026 by
CPI
“Anti-Monopoly” Antitrust Enforcement: Lessons Learned from the Biden Administration
Aug 24, 2026 by
Diana L. Moss
FTC v. Meta: The Importance of Quantitative Evidence in Antitrust
Aug 24, 2026 by
Dennis Carlton, John A. List, Allan Shampine, Hal Sider & Theresa Sullivan
Competitor Information Exchanges: Reducing Market Uncertainty Is What Matters, Not Level Of Detail
Aug 24, 2026 by
Kasia Czapracka, Assimakis Komninos, James Killick & Nina Frie
When Politics Meets Merger Control: 10 Transatlantic Takeaways
Aug 24, 2026 by
Rachel Brandenburger